Trovagene, University of Michigan to Collaborate on Pancreatic Cancer Monitoring, Early Detection | GenomeWeb

NEW YORK (GenomeWeb) – Trovagene said today that it is initiating a new multi-phased research collaboration with the University of Michigan Comprehensive Cancer Center in which Michigan investigators will use the company's KRAS ctDNA test and assess its utility in detecting early pancreatic cancers and monitoring patients as they undergo therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.